Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Community Pharmacists' Role in Colorectal Cancer Screening ACCN Research Roundtable Hershey, PA September 28, 2007 Co-Investigators: Cathy A. Coyne, MPH, PhD Division of Community Health Lehigh Valley Hospital Allentown, Pennsylvania Lesley-Ann Miller, PhD Drug Use Policy and Pharmacoeconomics MD Anderson Cancer Center University of Texas Linda Jacknowitz, MLS Cristina Demian, MD, MPH Mary Babb Randolph Cancer Center Cancer Prevention and Control West Virginia University Methodology Mailed survey (9-pages) Random sample of 1000 licensed pharmacists in West Virginia Notification letter sent, following by survey with coverletter Reminder postcard, replacement survey, telephone follow-up Results 333 pharmacists not eligible to participate 2 deceased 15 retired 45 surveys returned, address unknown 58 not practicing in West Virginia 213 did not have direct contact with patients Total eligible sample: 667 Respondents: 337 (50.5% response rate) Respondent Characteristics Gender (% male) 55.5 Mean age (yrs) 43.9 Degree (% respondents) BS 86.4 MS PharmD More than one 0.6 8.0 3.9 Pharmacy Setting (Percentage of respondents) Independent Pharmacy National Chain Pharmacy National Chain Grocery/Supermarket National Chain Department Store Regional Chain Pharmacy Type of county where pharmacist works (urban/rural) Own pharmacy/store 32.0 27.6 8.3 7.1 4.7 70.3/36.7 14.5 Percentage reporting proactive counseling services Diabetes Blood pressure screening 82.2 75.7 Smoking cessation Hormone replacement therapy Colorectal cancer screening Prostate cancer screening 75.4 40.7 13.6 12.2 Percentage of Community Pharmacists reporting potential barriers to patient counseling Percentage of respondents 100 80 Lack of reimbursement Lack of time 60 45.9 40 30.6 20.4 20 0 Lack of patient interest 30.3 Lack of pharmacist knowledge Community pharmacists’ perceived effectiveness of colorectal cancer screening tests for average risk patients 50+ year of age Percentage of respondents "very effective" 100 80.7 Colonoscopy 80 Flex Sig 60 40 20 0 51.9 FOBT 36.8 DCBE 31.2 Pharmacists don’t have role in cancer prevention counseling 78.6% disagree Pharmacists should only have responsibility to counsel about medications 77.2% disagree Community pharmacists’ agreement to statement indicating that they are confident in their ability to instruct patients on proper FOBT use 50 Percentage of respondents 41.2 40 Strongly agree Agree 30 24.9 0 Disagree 17.5 20 10 Undecided 8.3 Strongly disagree 7.7 FOBT kits for sale in pharmacy 22.7% None sold 1-5 kits sold/month 24% 52% Potential facilitators to pharmacists’ counseling patients about colorectal cancer screening 95.5 100 92.6 Percentage of respondents 85.7 80 Screening is cost effective 60 40 20 0 CRC is a serious public health problem CRC screening is as important as other screenings Pharmacist attitudes regarding counseling responsibilities Percentage that agree it is pharmacists’ responsibility to counsel patients about… 95.8 Percentage of respondents 100 FOBT 94.7 Sigmoid/colonoscopy Smoking cessation 80 74.6 Sun screen use PSA 60 40 20 0 37.1 40.5 Potential barriers to pharmacists’ counseling Patients about colorectal cancer screening Physicians are responsible 100 Percentage of respondents Pharmacists uncomfortable 80 Too busy 57 60 44.2 40 20 0 44.2 Likelihood of participating in training 120 100 95.8 Counseling- FOBT kit use Percentage of respondents 90.3 82.8 80 76.4 86.1 89.4 81.9 Counseling-Sigmoid/colonoscopy 82.2 76.8 Counseling -diabetes management Counseling -Smoking cessation 60 Guidelines-CRC Counsel-skin cancer prevention 40 Guidelines-breast cancer screening Guidelines-prostate cancer screening 20 0 Guidelines-cervical cancer